• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

SIV Vaccines

April 1, 2003

Two new-generation monovalent swine influenza vaccines - MaxiVac(r) H1N1 and MaxiVac(r) H3N2 - have been launched by Schering-Plough Animal Health Corp.

Two new-generation monovalent swine influenza vaccines - MaxiVac(r) H1N1 and MaxiVac(r) H3N2 - have been launched by Schering-Plough Animal Health Corp. "Each vaccine contains field-proven antigens of swine influenza virus (SIV) that have been used successfully in more than 75 million pigs nationwide," says Dr. Robyn Fleck, technical service veterinarian, Schering-Plough Animal Health. "Both vaccines also contain the field-proven adjuvant Emunade(r)."The new-generation monovalents are part of the MaxiVac(r) family - the only SIV line with a USDA-approved label for reduced shedding of H1N1 and H3N2 flu viruses. As with all MaxiVac vaccines, MaxiVac H1N1 and MaxiVac H3N2 contain Emunade, Schering-Plough's proprietary oil-in-water adjuvant that has demonstrated an excellent safety record."Emunade has been used for more than six years in M-Pac(r) mycoplasma pneumonia vaccine," Fleck says. "It syringes well with minimal tissue reaction. It is safe for use in weaning-age pigs and pregnant females. It also has only a 21-day withdrawal time."Studies show that most U.S. herds have been exposed to both H1N1 and the newer H3N2 subtypes, so many producers opt to use a product that contains both subtypes in one vaccine, such as MaxiVac(r) Excell or the new MaxiVac(r) Platinum, which also provides protection against mycoplasma pneumonia.Still, in some areas where either H1N1 or H3N2 is the predominant problem, producers and veterinarians still want the option and added flexibility of vaccinating for only one subtype.The H1N1 virus strain in MaxiVac H1N1 has been shown in studies to cross-react with recent U.S. isolates. The virus strain in MaxiVac H3N2 also has been carefully researched and is genetically and serologically similar to the H3N2 viruses circulating in U.S. swine.Both vaccines have been shown to reduce the clinical signs of swine influenza as well as viral shedding, which should reduce SIV exposure among animals and shorten the duration of disease in a herd, Fleck says.All MaxiVac vaccines contain viruses grown in a cell-culture system. The process assures consistency in the production of antigens and helps assure that they are relatively free from foreign proteins, she adds.Vials of the monovalent vaccines are available in 250-dose (500 mL), 125-dose (250 mL) or 50-dose (100 mL) vials for maximum flexibility.Each vaccine is indicated for use in healthy pigs 4 weeks of age or older. Pigs should be vaccinated with an initial 2 mL intramuscular dose and revaccinated two to three weeks later with another 2 mL dose of vaccine.

For fastest response call (800) 211-3573.

Related Content:

Products
 Vetstoria releases its Fill Rate platform
Vetstoria releases its Fill Rate platform
Communicating the importance of genetic screening
Communicating the importance of genetic screening
Study reveals Zymox Otic Plus is beneficial and effective
Study reveals Zymox Otic Plus is beneficial and effective

Advertisement

Latest News

The four-letter word to why you're burning out and feeling unproductive

Merck Manuals recognizes importance of One Health concept

Topical therapy and immunotherapy can save time and frustration with dermatology cases

Texas Tech appoints new faculty member with passion for animal agriculture

View More Latest News
Advertisement